Search Results
Aug 28, 2026, 03:55 ET NVIDIA DGX StationをベースとするMSI XpertStation WS300、販売開始
がNVIDIA DGX Stationアーキテクチャをベースとしており、現在出荷中であると発表しました。NVIDIA GB300 Grace Blackwell Ultra Desktop Superchipを搭載したこのデスクサイドAIスーパーコンピューターは、ASI、D&H、Neweggを通じて購入可能となり、企業のAI開発・導入においてデータセンタークラスのAI機能をより身近に利用できるようにします。
More news about: MSI
Aug 27, 2026, 23:32 ET MSI XpertStation WS300, 엔비디아 DGX 스테이션 기반으로 정식 출시
엔비디아 DGX 스테이션(NVIDIA DGX Station) 아키텍처를 기반으로 한 XpertStation WS300의 출하를 시작했다고 발표했다. 엔비디아 GB300 그레이스 블랙웰 울트라 데스크톱 슈퍼칩(NVIDIA GB300 Grace Blackwell Ultra Desktop Superchip)으로
More news about: MSI
Aug 27, 2026, 13:01 ET La XpertStation WS300 de MSI, basée sur la DGX Station de NVIDIA, est désormais disponible
sur l'architecture de la DGX Station de NVIDIA, était désormais disponible à la vente. Équipé de la GB300 Grace Blackwell Ultra Desktop Superchip de NVIDIA, ce supercalculateur
More news about: MSI
Aug 27, 2026, 12:30 ET MSI XpertStation WS300搭載NVIDIA DGX Station架構正式出貨
微星科技宣布，搭載NVIDIA DGX Station架構的XpertStation WS300正式出貨。這款桌邊型AI超級電腦採用NVIDIA GB300 Grace Blackwell Ultra Desktop Superchip，即日起可透過ASI、D&H及Newegg購買，讓企業能在桌邊部署資料中心等級AI運算能力，加速本地AI開發與部署。
More news about: 微星科技
Aug 27, 2026, 12:30 ET MSI XpertStation WS300 Based on NVIDIA DGX Station Now Available
on NVIDIA DGX Station architecture is now shipping. Powered by NVIDIA GB300 Grace Blackwell Ultra Desktop Superchip, the deskside AI supercomputer is now available
More news about: MSI
Aug 27, 2026, 12:30 ET MSI XpertStation WS300 Based on NVIDIA DGX Station Now Available
on NVIDIA DGX Station architecture is now shipping. Powered by NVIDIA GB300 Grace Blackwell Ultra Desktop Superchip, the deskside AI supercomputer is now available
More news about: MSI
Aug 27, 2026, 12:30 ET MSI XpertStation WS300 auf Basis der NVIDIA DGX Station ab sofort erhältlich
auf der NVIDIA-DGX-Station-Architektur, ab sofort ausgeliefert wird. Der auf dem NVIDIA GB300 Grace Blackwell Ultra Desktop Superchip basierende KI-Supercomputer für den Schreibtisch
More news about: MSI
Aug 27, 2026, 12:30 ET MSI XpertStation WS300 baseado na NVIDIA DGX Station já disponível
na arquitetura NVIDIA DGX Station, já está sendo comercializado. Equipado com o superchip NVIDIA GB300 Grace Blackwell Ultra Desktop, o supercomputador de IA para uso na mesa
More news about: MSI
Aug 27, 2026, 12:30 ET Ya está disponible MSI XpertStation WS300, basado en NVIDIA DGX Station
XpertStation WS300, basado en la arquitectura NVIDIA DGX Station. Impulsada por el chip NVIDIA GB300 Grace Blackwell Ultra Desktop Superchip, esta supercomputadora de IA para escritorio ya se puede
More news about: MSI
Aug 27, 2026, 12:30 ET Ya está disponible la MSI XpertStation WS300, basada en la NVIDIA DGX Station
en la arquitectura NVIDIA DGX Station. Equipada con el superchip de escritorio NVIDIA GB300 Grace Blackwell Ultra, esta supercomputadora de sobremesa con IA ya está disponible
More news about: MSI
Aug 25, 2026, 10:18 ET Humanity propose l'analyse de l'âge biologique aux États-Unis via questhealth.com
Quest Diagnostics (NYSE : DGX) ont annoncé aujourd'hui que Humanity Biological Age, le modèle de Humanity, scientifiquement validé permettant de mesurer l'âge biologique à partir
More news about: Humanity Health Inc.; Quest Diagnostics
Aug 25, 2026, 10:05 ET Humanity introduce el análisis de edad biológica en Estados Unidos a través de questhealth.com
Quest Diagnostics (NYSE: DGX) dieron a conocer hoy que Humanity Biological Age, el modelo científicamente validado de Humanity para medir la edad biológica a partir de los resultados
More news about: Humanity Health Inc.; Quest Diagnostics
Aug 25, 2026, 09:57 ET Humanity führt über questhealth.com die Analyse des biologischen Alters in den USA ein
Quest Diagnostics (NYSE: DGX) gaben heute bekannt, dass „Humanity Biological Age" – das wissenschaftlich validierte Modell von Humanity zur Bestimmung des biologischen Alters anhand
More news about: Humanity Health Inc.; Quest Diagnostics
Aug 25, 2026, 09:30 ET Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference
SECAUCUS, N.J., Aug. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance
More news about: Quest Diagnostics
Aug 25, 2026, 08:00 ET Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com
Quest Diagnostics (NYSE: DGX) today announced that Humanity Biological Age, Humanity's scientifically validated model for measuring biological age from biomarker lab test results,
More news about: Humanity Health Inc.; Quest Diagnostics
Aug 25, 2026, 08:00 ET Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com
Quest Diagnostics (NYSE: DGX) today announced that Humanity Biological Age, Humanity's scientifically validated model for measuring biological age from biomarker lab test results,
More news about: Humanity Health Inc.; Quest Diagnostics
Aug 24, 2026, 09:00 ET Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
SECAUCUS, N.J., Aug. 24, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief Financial Officer, will speak on the company's
More news about: Quest Diagnostics
Aug 24, 2026, 07:24 ET Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology
SECAUCUS, N.J., Aug. 24, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced two new developments for its Quest AD-Detect® portfolio of blood-based biomarker tests
More news about: Quest Diagnostics
Aug 12, 2026, 16:15 ET Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on October
More news about: Quest Diagnostics
Aug 06, 2026, 09:00 ET Linux Foundation Announces Key Industry Support for Linux Vendor Firmware Service
NVIDIA and our OEM partners are able to deliver a first-class update experience and rapid security responsiveness across the open source ecosystem. DGX Spark users can rely on NVIDIA for standardized, easily installed updates that seamlessly deliver new features and improvements. By supporting LVFS,
More news about: The Linux Foundation
Jul 30, 2026, 07:30 ET Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics
a new Health Trends® study from Quest Diagnostics (NYSE: DGX) and Hologic, Inc.
More news about: Quest Diagnostics
Jul 23, 2026, 07:36 ET Vertiv Infrastructure Helps Bring NVIDIA AI Computing Capability to the Naval Postgraduate School
requires power, cooling and physical infrastructure engineered to work together," said Charlie Boyle, vice president of DGX systems at NVIDIA. "Together with Vertiv, we're bringing the NVIDIA DGX GB300 system online at the Naval Postgraduate School, giving researchers and faculty the infrastructure to advance
More news about: Vertiv Holdings Co
Jul 23, 2026, 06:45 ET Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
SECAUCUS, N.J., July 23, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the second quarter ended June 30, 2026.
More news about: Quest Diagnostics
Jul 20, 2026, 10:31 ET Degenerative Disc Disease Market to Observe Stupendous Growth at ~19% CAGR by 2036, Due to Launch of Novel Drug Classes Such as Cell Replacement, NF-kappa B Inhibitors, Cartilage Regeneration via TGF-β1 Expression, and Others | DelveInsight
accelerated Phase III clinical development program, comprising two identical parallel studies approved by the FDA: the pivotal DGX-A02 (PIVOT) trial and the confirmatory DGX-A03 (CONFIRM) trial.BioRestorative Therapies' BRTX-100 is an investigational autologous mesenchymal stem cell therapy
More news about: DelveInsight Business Research, LLP
Jul 08, 2026, 08:52 ET Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
MRDSECAUCUS, N.J., July 8, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced it is integrating its Haystack MRD® ctDNA test and Comprehensive Genomic
More news about: Quest Diagnostics